Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial

Ivo W. Tremont-Lukats, Bin S. Teh

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	S589-S591
Journal	Translational Cancer Research
Volume	8
DOIs	https://doi.org/10.21037/tcr.2019.06.43
State	Published - Dec 1 2019

ASJC Scopus subject areas

@article{ea8682e9abff4b77a52eb139b71f5ef4,

title = "Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial",

author = "Tremont-Lukats, {Ivo W.} and Teh, {Bin S.}",

year = "2019",

month = dec,

day = "1",

doi = "10.21037/tcr.2019.06.43",

language = "English (US)",

volume = "8",

pages = "S589--S591",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter

T2 - Lessons from the CeTeG/NOA-09 trial

AU - Tremont-Lukats, Ivo W.

AU - Teh, Bin S.

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85078921608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078921608&partnerID=8YFLogxK

U2 - 10.21037/tcr.2019.06.43

DO - 10.21037/tcr.2019.06.43

M3 - Comment/debate

AN - SCOPUS:85078921608

SN - 2218-676X

VL - 8

SP - S589-S591

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -